Effects of NFκB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line

Biomaterials

Volumn 23, Issue 13, 2002, Pages 2773-2781

  Gill, Jagjit S ^a   Zhu, Xun ^a   Moore, Michael J ^a   Lu, Lichun ^a   Yaszemski, Michael J ^a   Windebank, Anthony J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Biodegradable microparticles; Cell growth; Controlled release; Glioblastoma (GBM); Nuclear factor kappa B (NF B); Phosphorothioated decoy oligonucleotides (ODNS); Poly(DL lactic co glycolic acid) (PLGA)

Indexed keywords

BIODEGRADATION; CELL CULTURE; ENCAPSULATION; PROTEINS;

MICROPARTICLES;

POLYMERS;

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OLIGONUCLEOTIDE; POLYGLACTIN; POLYMER; BIOMATERIAL; CDK4 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; LACTIC ACID; ONCOPROTEIN; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; BIODEGRADABILITY; CANCER CELL CULTURE; CELL COUNT; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; ENCAPSULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ACTIVE TRANSPORT; BIOREMEDIATION; CELL CULTURE; CELL DIVISION; CELL LINE; CYTOLOGY; GLIA; IMMUNOBLOTTING; KINETICS; METABOLISM; TIME; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; CELLS, CULTURED; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; GLIOBLASTOMA; HUMANS; IMMUNOBLOTTING; KINETICS; LACTIC ACID; NEUROGLIA; NF-KAPPA B; OLIGONUCLEOTIDES; POLYGLYCOLIC ACID; POLYMERS; PROTO-ONCOGENE PROTEINS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0036011294     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(02)00013-3     Document Type: Article

References (45)

1. The future of therapy for glioblastoma
2. Radiosurgery as part of the initial management of patients with malignant gliomas
3. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours
4. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations
5. Accumulation of wild type p53 protein in human astrocytomas
6. Prognostic significance of p53 immunoreactivity in adult patients with supratentorial fibrillary astrocytic neoplasms
7. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity
8. Alterations of the TP53 gene in human gliomas
9. The molecular biology and molecular genetics of astrocytic neoplasms
10. Prognostic factors in malignant glioma: Influence of the overexpression of oncogene and tumor-suppressor gene products on survival
11. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells
12. Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1
13. Function and activation of NF-kappa B in the immune system
14. Highly expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells
15. Bcl-2 suppresses apoptosis resulting from disruption of the NF-kappa B survival pathway
16. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer
17. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity
18. The I kappa B proteins: Multifunctional regulators of Rel/NF-kappa B transcription factors
19. The I kappa B proteins: Members of a multifunctional family
20. Rel/NF-kappa B/I kappa B family: Intimate tales of association and dissociation
21. NF-kappa B: Ten years after
22. P105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction
23. Ceramide initiates NFkappaB-mediated caspase activation in neuronal apoptosis
24. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice
25. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres
26. Poly(alpha-hydroxy acids): Carriers for bone morphogenetic proteins
27. Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles
28. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issues
29. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders
30. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles
31. Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates
32. Controlled release of NFkB decoy oligonucleotides from biodegradable polymer microparticles
33. Antisense oligonucleotides: Strategies for delivery
34. Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines
35. Gastrin inhibits motility, decreases cell death levels and increases proliferation in human glioblastoma cell lines
36. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
37. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle
38. D-type cyclin-dependent kinase activity in mammalian cells
39. Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1
40. Disorders in cell circuitry associated with multistage carcinogenesis: Exploitable targets for cancer prevention and therapy
41. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells
42. Interleukin-11. A gp130 cytokine
43. Activation of the nuclear factor-kappaB is a key event in brain tolerance
44. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice
45. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres